This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Renal Cancer
Conferences
AUA 2014
Recent Abstracts
#AUA14 - Multiparametric prostate MRI and MRI/ultrasound fusion biopsy in the follow-up of prostate cancer progression for men on active surveillance - Slide Presentation
June 26, 2014
#AUA14 - AUA Guideline: Medical management of kidney stones - Slide Presentation
May 28, 2014
#AUA14 - Poster: Retrospective evaluation of efficacy and safety of Argus sling for treatment of male stress urinary incontinence: The Canadian experience
May 27, 2014
#AUA14 - Poster: Stress urinary incontinence outcomes following transvaginal sling incision
May 27, 2014
#AUA14 - Poster: Sexual dysfunction and dyspareunia in the setting of vaginal mesh exposure
May 27, 2014
#AUA14 - Poster: Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection
May 27, 2014
#AUA14 - AUA Guideline: Diagnosis and treatment of overactive bladder (non-neurogenic)
May 27, 2014
#AUA14 - Poster: Multicenter validation study of a tissue epigenenic assay to predict histopathologically cancer-negative repeat prostate biopsies
May 27, 2014
#AUA14 - Poster: Overactive bladder patients ≥ 65 years of age have a similar efficacy and safety profile with onabotulinumtoxinA as patients less than 65 years of age
May 27, 2014
#AUA14 - Poster: Long-term efficacy and safety of repeat onabotulinumtoxinA treatment in overactive bladder syndrome and urinary incontinence: Third interim analysis, median 2.4 years follow-up
May 27, 2014
#AUA14 - Poster: Reduction in urinary incontinence and improvement in quality of life with onabotulinumtoxinA in overactive bladder patients is unaffected by the use of clean intermittent catheterization or the presence of urinary tract infection
May 27, 2014
#AUA14 - Poster: Prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with prostatectomy
May 27, 2014
#AUA14 - Poster: Validation of a 46-gene cell cycle progression (CCP) RNA signature for predicting prostate cancer death in a conservatively managed watchful waiting needle biopsy cohort
May 27, 2014
#AUA14 - Poster: Predicting radical prostatectomy outcome among men who upgrade from clinical Gleason 6 to pathologic Gleason 7
May 27, 2014
#AUA14 - Poster: Anticholinergic cycling and treatment outcomes in overactive bladder patients with urinary incontinence
May 27, 2014
#AUA14 - Impact of female stress urinary incontinence surgery on pre-op overactive bladder symptoms - Session Highlights
May 22, 2014
#AUA14 - Poster: Treatment practice patterns in metastatic castration-resistant prostate cancer patients prior to receiving sipuleucel-T: Data from PROCEED
May 21, 2014
#AUA14 - Poster: Further characterization of the effects of prior or no prior docetaxel therapy on CRPC patients with bone metastases receiving Ra-223 in the phase 3 ALSYMPCA trial
May 21, 2014
#AUA14 - Poster: Impact of prior endocrine therapy on clinical benefit of abiraterone acetate in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302
May 21, 2014
#AUA14 - Poster: An indirect treatment comparison and cost-effectiveness analysis of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer post chemotherapy
May 21, 2014
Page 1 of 9
Start
Prev
1
2
3
4
5
6
7
8
9
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free